首页> 美国卫生研究院文献>PLoS Clinical Trials >Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema

【2h】

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema

机译：糖尿病性黄斑水肿玻璃体内地塞米松植入（Ozurdex）后一年的随访期间的形态和功能

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

BackgroundTo investigate changes in macular morphology and function after an intravitreal dexamethasone implant for diabetic macular edema (DME).

机译：背景研究玻璃体内地塞米松植入治疗糖尿病性黄斑水肿（DME）后黄斑形态和功能的变化。

著录项

期刊名称 PLoS Clinical Trials
作者
Rodolfo Mastropasqua; Lisa Toto; Enrico Borrelli; Luca Di Antonio; Chiara De Nicola; Alessandra Mastrocola; Marta Di Nicola; Paolo Carpineto;
展开▼
作者单位

展开▼
年(卷),期 2010(10),12
年度 2010
页码 e0145663
总页数 11
原文格式 PDF
正文语种
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Intravitreal dexamethasone implant Ozurdex in the treatment of diabetic macular edema in patients not previously treated with any intravitreal drug: a prospective 12-month follow-up study [J] . Menezo Marc, Roca Manuel, Menezo Victor, Current medical research and opinion . 2019,第12期

机译：玻璃体内地塞米松植入Ozurdex在治疗糖尿病性黄斑水肿的患者中未治疗任何玻璃体内药物未治疗的患者：一项潜在的12个月后续研究
2. The use of fluocinolone acetonide implant(ILUVIEN) in patients with diabetic macular edema(DME) previously treated with dexamethasone intravitreal implant(OZURDEX) - Efficacy and safety outcomes from clinical practice in Glasgow, Scotland [J] . Rajasekaran Sridevi, Mulla Umaima, Drummond Suzannah, Investigative ophthalmology & visual science . 2017,第8期

机译：使用糖尿病黄斑水肿（DME）患者使用嗜血体植物植入物（ILUVIEN）以前用地塞米松玻璃体植入物（Ozurdex） - 来自苏格兰格拉斯哥临床实践的疗效和安全结果
3. The use of fluocinolone acetonide implant(ILUVIEN) in patients with diabetic macular edema(DME) previously treated with dexamethasone intravitreal implant(OZURDEX) - Efficacy and safety outcomes from clinical practice in Glasgow, Scotland [J] . Rajasekaran Sridevi, Mulla Umaima, Drummond Suzannah, Investigative ophthalmology & visual science . 2017,第8期

机译：使用糖尿病黄斑水肿（DME）患者使用嗜血体植物植入物（ILUVIEN）以前用地塞米松玻璃体植入物（Ozurdex） - 来自苏格兰格拉斯哥临床实践的疗效和安全结果
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Combined Phacoemulsification and Intravitreal Dexamethasone Implant (Ozurdex®) in Diabetic Patients with Coexisting Cataract and Diabetic Macular Edema [O] . Claudio Furino, Francesco Boscia, Alfredo Niro, 2017

机译：合并白内障和糖尿病性黄斑水肿的糖尿病患者超声乳化和玻璃体内地塞米松联合植入（Ozurdex®）
7. Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema. [O] . Rodolfo Mastropasqua, Lisa Toto, Enrico Borrelli, 2015

机译：玻璃体腔注射地塞米松（Ozurdex）治疗糖尿病性黄斑水肿患者一年随访期的形态学和功能。

Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema

摘要

著录项

相似文献

相关主题

期刊订阅